Melanoma Detection by Oblique-Incidence Optical Spectroscopy
NCT00526032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 490
Last updated 2012-01-31
Summary
Primary Objectives:
* To establish a statistically significant database: With Spectroscopic Oblique-Incidence Reflectometry (OIR) experimental system, we will obtain OIR spatio-spectral images of 1,000 human skin non-melanocytic and melanocytic lesions that, based on clinical diagnosis, are routinely biopsied and submitted for histopathologic diagnosis and of the adjacent normal skin for self-referencing. The experimental database will contain demographic information, clinical diagnoses, clinical images, OIR images, histopathologic diagnoses, and morphometric data on the lesions.
* To develop and validate a diagnostic algorithm:
1. Classification: A subset (\~50%) of OIR images collected will be used to complete the development of state-of-the-art image processing algorithms to extract robustly effective diagnostic features.
2. Blind Testing and Evaluation: The algorithms established will be evaluated and validated in a prospective blind-test fashion using the complementary subset of the database that was not involved in designing the classifier. The sensitivity and specificity of the classification system will be evaluated based on the receiver-operating-characteristic (ROC) curve.
* To identify the pathophysiologic parameters responsible for the diagnostic optical features: The anatomic and physiologic sources of the diagnostic optical signatures will be identified by comparative analyses using the OIR images, microscopic histomorphometric techniques and theoretical modeling to test the following hypotheses:
1. The calculated differences in hemoglobin oxygen saturation.
2. Comparisons of the calculated size distributions of skin scattering centers with histologic and morphometric analyses of various cellular and tissue components of the skin lesions.
3. The relative densities and distributions of the different anatomic and physiologic diagnostic features within the interrogation volumes are important diagnostic factors in OIR.
Conditions
Interventions
- PROCEDURE
-
OIR Imaging
Images from 4 different positions will be taken per lesion. The entire imaging procedure will take about 5 minutes per lesion.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Madeleine Duvic, MD · M.D. Anderson Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope
NCT03069846 ·Status: UNKNOWN ·Phase: NA
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
At-Home Dermoscopy Artificial Intelligence
NCT05321784 ·Status: TERMINATED ·Phase: NA
-
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
NCT00588315 ·Status: ACTIVE_NOT_RECRUITING
-
MicroRNA Expression and Function in Cutaneous Malignant Melanoma
NCT00536029 ·Status: COMPLETED
-
Optical Spectroscopy for Cutaneous Cancer
NCT02522793 ·Status: COMPLETED
-
Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits
NCT04550000 ·Status: COMPLETED
-
Natural History Study of Moles and Suspicious Melanoma
NCT00288938 ·Status: COMPLETED
-
Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
NCT05068310 ·Status: RECRUITING
-
Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping
NCT05389085 ·Status: COMPLETED ·Phase: NA
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
NCT01205815 ·Status: RECRUITING
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
New Biopsy Technique for Uveal Melanoma
NCT01924923 ·Status: COMPLETED
-
Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma
NCT00897624 ·Status: COMPLETED
-
Sample Collection From Melanoma Patients
NCT00507325 ·Status: TERMINATED
-
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
NCT00835133 ·Status: ACTIVE_NOT_RECRUITING
-
Optical Coherence Tomography Guided C&D
NCT04510727 ·Status: WITHDRAWN ·Phase: NA
-
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )
NCT03493230 ·Status: COMPLETED ·Phase: NA
-
The Identification of Novel Prognostic Markers in Melanoma
NCT01002560 ·Status: UNKNOWN
-
Metabolic Phenotypes in Melanoma
NCT05570227 ·Status: RECRUITING ·Phase: NA